Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
NCT02426229
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Scleroderma
Interstitial Lung Disease
Interventions
DRUG:
dabigatran etexilate
Sponsor
Medical University of South Carolina
Collaborators
[object Object]